20 January 2016 - Deborah Wilkes
Archived
Bayer has opened a "state-of-the-art" manufacturing plant in China that will boost its capacity for Traditional Chinese Medicine (TCM) products by a "factor of three in 2016".
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.